Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 617

    1.

    Sensitivity to acute insulin-mediated suppression of plasma free fatty acids is not a determinant of fasting VLDL triglyceride secretion in healthy humans.

    Carpentier A, Patterson BW, Leung N, Lewis GF.

    Diabetes. 2002 Jun;51(6):1867-75.PMID: 12031975 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The insulin resistance syndrome and the binding capacity of cortisol binding globulin (CBG) in men and women.

    Fernández-Real JM, Grasa M, Casamitjana R, Ricart W.

    Clin Endocrinol (Oxf). 2000 Jan;52(1):93-9.PMID: 10651759 [PubMed - indexed for MEDLINE]Related articles

    3.

    Correlates of plasma very-low-density lipoprotein concentration and composition in premenopausal women.

    Després JP, Moorjani S, Pouliot MC, Tremblay A, Nadeau A, Lupien PJ, Bouchard C.

    Metabolism. 1990 Jun;39(6):577-83.PMID: 2191186 [PubMed - indexed for MEDLINE]Related articles

    4.

    Plasma oestrone-fatty acid ester levels are correlated with body fat mass in humans.

    Fernández-Real JM, Sanchis D, Ricart W, Casamitjana R, Balada F, Remesar X, Alemany M.

    Clin Endocrinol (Oxf). 1999 Feb;50(2):253-60.PMID: 10396370 [PubMed - indexed for MEDLINE]Related articles

    5.

    The effect of systemic versus portal insulin delivery in pancreas transplantation on insulin action and VLDL metabolism.

    Carpentier A, Patterson BW, Uffelman KD, Giacca A, Vranic M, Cattral MS, Lewis GF.

    Diabetes. 2001 Jun;50(6):1402-13.PMID: 11375342 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans.

    Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G.

    J Clin Invest. 1995 Jan;95(1):158-66.PMID: 7814610 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.

    Oakes ND, Thalén PG, Jacinto SM, Ljung B.

    Diabetes. 2001 May;50(5):1158-65.PMID: 11334421 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Postprandial triglyceride response in visceral obesity in men.

    Couillard C, Bergeron N, Prud'homme D, Bergeron J, Tremblay A, Bouchard C, Mauriège P, Després JP.

    Diabetes. 1998 Jun;47(6):953-60.PMID: 9604874 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Very-low-density lipoprotein triglyceride metabolism in non-insulin-dependent diabetes mellitus. Relationship to plasma insulin and free fatty acids.

    Howard BV, Reitman JS, Vasquez B, Zech L.

    Diabetes. 1983 Mar;32(3):271-6.PMID: 6337905 [PubMed - indexed for MEDLINE]Related articles

    10.

    VLDL production is decreased to a similar extent by acute portal vs. peripheral venous insulin.

    Lewis GF, Zinman B, Uffelman KD, Szeto L, Weller B, Steiner G.

    Am J Physiol. 1994 Oct;267(4 Pt 1):E566-72.PMID: 7943306 [PubMed - indexed for MEDLINE]Related articles

    11.

    The relationship in African-Americans of sex differences in insulin-mediated suppression of nonesterified fatty acids to sex differences in fasting triglyceride levels.

    Sumner AE, Kushner H, Tulenko TN, Falkner B, Marsh JB.

    Metabolism. 1997 Apr;46(4):400-5.PMID: 9109843 [PubMed - indexed for MEDLINE]Related articles

    12.

    Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans.

    Lewis GF, Vranic M, Harley P, Giacca A.

    Diabetes. 1997 Jul;46(7):1111-9.PMID: 9200644 [PubMed - indexed for MEDLINE]Related articles

    13.

    Hepatic fat content is a determinant of postprandial triglyceride levels in type 2 diabetes mellitus patients with normal fasting triglyceride.

    Nimitphong H, Phongkitkarun S, Rattarasarn C, Kongsooksai A, Chanprasertyothin S, Bunnag PA, Puavilai G.

    Metabolism. 2008 May;57(5):644-9.PMID: 18442627 [PubMed - indexed for MEDLINE]Related articles

    14.

    Association of insulin resistance and hyperinsulinemia with disturbed lipid metabolism in patients with essential hypertension.

    Agata J, Miyazaki Y, Takada M, Murakami H, Masuda A, Miura T, Ura N, Shimamoto K.

    Hypertens Res. 1998 Mar;21(1):57-62.PMID: 9582109 [PubMed - indexed for MEDLINE]Related articles

    15.

    Associations between insulin sensitivity, and free fatty acid and triglyceride metabolism independent of uncomplicated obesity.

    Bruce R, Godsland I, Walton C, Crook D, Wynn V.

    Metabolism. 1994 Oct;43(10):1275-81.PMID: 7934980 [PubMed - indexed for MEDLINE]Related articles

    17.

    Serum ferritin as a component of the insulin resistance syndrome.

    Fernández-Real JM, Ricart-Engel W, Arroyo E, Balançá R, Casamitjana-Abella R, Cabrero D, Fernández-Castañer M, Soler J.

    Diabetes Care. 1998 Jan;21(1):62-8.PMID: 9580307 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Metabolic effects of Troglitazone in patients with diet-controlled type 2 diabetes.

    Robinson AC, Jeffs JA, Gray RG, Bannister PA, Mather H, Gallagher JJ, Robinson S, Nattrass M, Venkatesan S, Halliday D, Johnston DG.

    Eur J Clin Invest. 2004 Jan;34(1):29-36.PMID: 14984435 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride production.

    Wang W, Basinger A, Neese RA, Shane B, Myong SA, Christiansen M, Hellerstein MK.

    Am J Physiol Endocrinol Metab. 2001 Mar;280(3):E540-7.PMID: 11171611 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Estimated liver weight is directly related to hepatic very low-density lipoprotein-triglyceride secretion rate in men.

    Tsekouras YE, Magkos F, Kavouras SA, Panagiotakos DB, Sidossis LS.

    Eur J Clin Invest. 2008 Sep;38(9):656-62.PMID: 18837742 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data